Skinvisible annual free cash flow
2019
2020
2021
2022
2023
2024
2025
Skinvisible Free Cash Flow (FCF) History (SKVI)
Skinvisible reported −$42,496 in free cash flow for fiscal 2025, an increase of $36,556 from the previous fiscal year, with a free cash flow margin of −212.48%.
View full Skinvisible company overviewSkinvisible free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$42,496 | $36,556 | — | −212.48% |
| 2024 | 2024-12-31 | −$79,052 | $7,438 | — | −395.26% |
| 2023 | 2023-12-31 | −$86,490 | −$129,130 | — | −432.45% |
| 2022 | 2022-12-31 | $42,640 | −$311,101 | −87.95% | +15.27% |
| 2021 | 2021-12-31 | $353,741 | $324,743 | +1119.88% | +53.32% |
| 2020 | 2020-12-31 | $28,998 | $183,326 | — | +19.00% |
| 2019 | 2019-12-31 | −$154,328 | — | — | −366.87% |
Skinvisible quarterly free cash flow
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q3.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2025 | 2025-09-30 | $523 | $26,113 | — | +10.46% |
| Q3 2024 | 2024-09-30 | −$12,542 | $39,698 | — | −250.84% |
| Q4 2023 | 2023-12-31 | −$3,843 | $29,080 | — | −76.86% |
| Q3 2023 | 2023-09-30 | −$4,819 | −$158,633 | — | −96.38% |
| Q2 2023 | 2023-06-30 | −$25,590 | −$75,338 | — | −511.80% |
| Q1 2023 | 2023-03-31 | −$52,240 | −$218,532 | — | −1044.80% |
| Q3 2022 | 2022-09-30 | −$32,923 | −$16,810 | — | −353.40% |
| Q4 2021 | 2021-12-31 | $153,814 | $123,637 | +409.71% | +60.83% |
| Q3 2021 | 2021-09-30 | $49,748 | $72,718 | — | +44.65% |
| Q2 2021 | 2021-06-30 | $166,292 | $127,782 | +331.82% | +57.92% |
| Q1 2021 | 2021-03-31 | −$16,113 | $606 | — | −133.71% |
| Q4 2020 | 2020-12-31 | $30,177 | $118,209 | — | +24.46% |
| Q3 2020 | 2020-09-30 | −$22,970 | −$30,395 | — | −549.13% |
| Q2 2020 | 2020-06-30 | $38,510 | $65,354 | — | +427.89% |
| Q1 2020 | 2020-03-31 | −$16,719 | $30,158 | — | −104.16% |
| Q4 2019 | 2019-12-31 | −$88,032 | — | — | −899.48% |
| Q3 2019 | 2019-09-30 | $7,425 | — | — | +65.74% |
| Q2 2019 | 2019-06-30 | −$26,844 | — | — | −212.76% |
| Q1 2019 | 2019-03-31 | −$46,877 | — | — | −560.26% |
Skinvisible free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $28,998 to −$42,496, a net decrease of $71,494. Skinvisible's latest reported quarter, Q3 2025, generated $523 in free cash flow, an increase of $26,113 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Skinvisible filings at SEC.gov ↗